Medicines (NASDAQ:MDCO) reported Q1 2018 earnings this Morning, coming in at ($0.76) per share, beating Wall Street’s estimates of ($0.80) per Share. Revenue for the quarter came in at $7.71 million missing the streets estimates of $9.21 million Recent Insider Trading for Medicines (NASDAQ:MDCO)
- On 4/16/2018 Armin M. Kessler, Director, sold 20,000 with an average share price of $28.71 per share and the total transaction amounting to $574,200.00.
- On 3/21/2018 William Crouse, Director, sold 7,500 with an average share price of $32.26 per share and the total transaction amounting to $241,950.00.
- On 12/15/2017 Clive Meanwell, CEO, sold 136,250 with an average share price of $27.24 per share and the total transaction amounting to $3,711,450.00.
- On 12/8/2017 Fredric N Eshelman, Insider, bought 200,000 with an average share price of $26.56 per share and the total transaction amounting to $5,312,000.00.
- On 11/29/2017 Alexander J Denner, Director, bought 170,000 with an average share price of $30.03 per share and the total transaction amounting to $5,105,100.00.
- On 2/7/2017 William Bernard O’connor, CFO, sold 25,833 with an average share price of $46.20 per share and the total transaction amounting to $1,193,484.60.
Dividend History for Medicines (NASDAQ:MDCO)
Recent Trading for Medicines (NASDAQ:MDCO) Shares of Medicines closed the previous trading session at 29.24 up +0.23 0.79% with 29.239999771118164 shares trading hands.